Literature DB >> 31075229

Molecular basis for the different interactions of congeneric substrates with the polyspecific transporter AcrB.

Ivana Malvacio1, Rosa Buonfiglio2, Noemi D'Atanasio2, Giovanni Serra1, Andrea Bosin1, Francesco Paolo Di Giorgio2, Paolo Ruggerone1, Rosella Ombrato3, Attilio Vittorio Vargiu4.   

Abstract

The drug/proton antiporter AcrB, which is part of the major efflux pump AcrABZ-TolC in Escherichia coli, is the paradigm transporter of the resistance-nodulation-cell division (RND) superfamily. Despite the impressive ability of AcrB to transport many chemically unrelated compounds, only a few of these ligands have been co-crystallized with the protein. Therefore, the molecular features that distinguish good substrates of the pump from poor ones have remained poorly understood to date. In this work, a thorough in silico protocol was employed to study the interactions of a series of congeneric compounds with AcrB to examine how subtle chemical differences affect the recognition and transport of substrates by this protein. Our analysis allowed us to discriminate among different compounds, mainly in terms of specific interactions with diverse sub-sites within the large distal pocket of AcrB. Our findings could provide valuable information for the design of new antibiotics that can evade the antimicrobial resistance mediated by efflux pump machinery.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AcrB; Efflux pumps; Molecular docking; Molecular dynamics; Multidrug resistance

Mesh:

Substances:

Year:  2019        PMID: 31075229     DOI: 10.1016/j.bbamem.2019.05.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta Biomembr        ISSN: 0005-2736            Impact factor:   3.747


  4 in total

1.  Molecular Interactions of Carbapenem Antibiotics with the Multidrug Efflux Transporter AcrB of Escherichia coli.

Authors:  Alessio Atzori; Giuliano Malloci; Francesca Cardamone; Andrea Bosin; Attilio Vittorio Vargiu; Paolo Ruggerone
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

2.  Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps.

Authors:  Coline Plé; Heng-Keat Tam; Anais Vieira Da Cruz; Nina Compagne; Juan-Carlos Jiménez-Castellanos; Reinke T Müller; Elizabeth Pradel; Wuen Ee Foong; Giuliano Malloci; Alexia Ballée; Moritz A Kirchner; Parisa Moshfegh; Adrien Herledan; Andrea Herrmann; Benoit Deprez; Nicolas Willand; Attilio Vittorio Vargiu; Klaas M Pos; Marion Flipo; Ruben C Hartkoorn
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 14.919

3.  Structural Insights into the Substrate Transport Mechanisms in GTR Transporters through Ensemble Docking.

Authors:  Carlos Peña-Varas; Christa Kanstrup; Ariela Vergara-Jaque; Mariela González-Avendaño; Christoph Crocoll; Osman Mirza; Ingo Dreyer; Hussam Nour-Eldin; David Ramírez
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

4.  Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.

Authors:  Elizabeth M Grimsey; Chiara Fais; Robert L Marshall; Vito Ricci; Maria Laura Ciusa; Jack W Stone; Alasdair Ivens; Giuliano Malloci; Paolo Ruggerone; Attilio V Vargiu; Laura J V Piddock
Journal:  mBio       Date:  2020-06-02       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.